Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by BELLUS Health Inc. BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders June 16, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition May 16, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU GSK TSX:BLU BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights May 12, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Announces Meeting Updates April 26, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health April 18, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU GSK TSX:BLU BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation April 05, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Reports Year 2022 Financial Results and Business Highlights March 21, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference March 01, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting February 08, 2023 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights November 14, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences November 10, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting October 10, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Present at the H.C. Wainwright Global Investment Conference September 06, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022 August 22, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights August 10, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States July 18, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States July 13, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States July 13, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough July 12, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Participate in the William Blair Biotech Focus Conference July 05, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Participate in the Jefferies Healthcare Conference June 01, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights May 11, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference May 02, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health to Participate in Multiple Upcoming Investor Conferences April 25, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Reports Year 2021 Financial Results and Business Highlights February 23, 2022 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States December 17, 2021 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States December 14, 2021 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States December 13, 2021 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough December 13, 2021 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights November 10, 2021 From BELLUS Health Inc. Via Business Wire Tickers BLU TSX:BLU Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
